[1]
“Clinical and immunological efficiency of different therapy schemes in patients with infectious mononucleosis caused by Epstein-Barr virus”, J. V. N. Karazin Khark. Nat. Univ., Ser. Med., no. 43, Dec. 2021, doi: 10.26565/2313-6693-2021-43-08.